Abstract
The Biodiversity2Drugs European Program aims to identify peptides in species from Terrestrial biodiversity organisms, an important class of natural products, unexplored for discovering nature's hits/leads, aiming for pharmacological prototypes, that could impact the pharmaceutical section in European Community and global competitiveness, through a sustainable and ecologically development…